Catalogo dei prodotti della ricerca

Italy experienced one of the world's deadliest COVID-19 outbreaks and healthcare systems had to instantly reorganise activity. The Italian Radiation Oncology Departments adapted numerous solutions to minimize the disruptions. Information technologies, treatment prioritization and implementation of hypofractionation and protection procedures allowed balancing between cancer patient care and patient/healthcare workers safety.

COVID-19 outbreak and cancer radiotherapy disruption in Italy: survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) / Alicja Jereczek-Fossa, Barbara; Pepa, Matteo; Marvaso, Giulia; Bruni, Alessio; e Bastia, Michela Buglione di Monale; Catalano, Gianpiero; Riccardo Filippi, Andrea; Franco, Pierfrancesco; Antonietta Gambacorta, Maria; Genovesi, Domenico; Iatì, Giuseppe; Magli, Alessandro; Marafioti, Luigi; Meattini, Icro; Merlotti, Anna; Mignogna, Marcello; Musio, Daniela; Pacelli, Roberto; Pergolizzi, Stefano; Tombolini, Vincenzo; Trovò, Marco; Ricardi, Umberto; Maria Magrini, Stefano; Corvò, Renzo; Donato, Vittorio. - In: RADIOTHERAPY AND ONCOLOGY. - ISSN 0167-8140. - 149:(2020), pp. 89-93. [10.1016/j.radonc.2020.04.061]

COVID-19 outbreak and cancer radiotherapy disruption in Italy: survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

Vincenzo Tombolini
Data Curation
;Vittorio Donato
Ultimo
Data Curation
2020

Abstract

Italy experienced one of the world's deadliest COVID-19 outbreaks and healthcare systems had to instantly reorganise activity. The Italian Radiation Oncology Departments adapted numerous solutions to minimize the disruptions. Information technologies, treatment prioritization and implementation of hypofractionation and protection procedures allowed balancing between cancer patient care and patient/healthcare workers safety.
2020
AIRO (Italian Association of Radiotherapy and Clinical Oncology); COVID-19; Italy; radiation oncology; survey; COVID-19; disease outbreaks; humans; Italy; neoplasms; SARS-CoV-2; surveys and questionnaires; Betacoronavirus; Coronavirus infections; medical oncology; pandemics; pneumonia, viral
01 Pubblicazione su rivista::01a Articolo in rivista
COVID-19 outbreak and cancer radiotherapy disruption in Italy: survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) / Alicja Jereczek-Fossa, Barbara; Pepa, Matteo; Marvaso, Giulia; Bruni, Alessio; e Bastia, Michela Buglione di Monale; Catalano, Gianpiero; Riccardo Filippi, Andrea; Franco, Pierfrancesco; Antonietta Gambacorta, Maria; Genovesi, Domenico; Iatì, Giuseppe; Magli, Alessandro; Marafioti, Luigi; Meattini, Icro; Merlotti, Anna; Mignogna, Marcello; Musio, Daniela; Pacelli, Roberto; Pergolizzi, Stefano; Tombolini, Vincenzo; Trovò, Marco; Ricardi, Umberto; Maria Magrini, Stefano; Corvò, Renzo; Donato, Vittorio. - In: RADIOTHERAPY AND ONCOLOGY. - ISSN 0167-8140. - 149:(2020), pp. 89-93. [10.1016/j.radonc.2020.04.061]
01a Articolo in rivista
File allegati a questo prodotto
File Dimensione Formato  
Jereczek-Fossa_COVID-19_2020.pdf

accesso aperto

Note: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215158/
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 535.09 kB
Formato Adobe PDF
535.09 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1487245
Citazioni
  • ???jsp.display-item.citation.pmc??? 27
  • Scopus 42
  • ???jsp.display-item.citation.isi??? 42
social impact